AAAAAA
Results: 1-25/50
Authors:
Balaji, KC
Huryk, RF
Verhulst, S
Fair, WR
Citation: Kc. Balaji et al., Growth of heterotopic LNCaP prostate cancer tumor in nude mice is not affected by dietary calcium, PROSTATE, 48(4), 2001, pp. 265-273
Authors:
Carroll, PR
Fair, WR
Grossfeld, GD
Heston, WDW
Lieberman, R
Malkowicz, SB
Stricker, HJ
Sylvester, J
Peehl, DM
Meyer, F
Hart, C
Citation: Pr. Carroll et al., Overview consensus statement, UROLOGY, 58(2A), 2001, pp. 1-4
Authors:
Fair, WR
Trachtenberg, J
Bubley, GJ
Heston, WD
Peehl, DM
Newling, DWW
Citation: Wr. Fair et al., Discussion following Dr. William R. Fair's presentation of Dr. Paul F. Schellhammer's paper, UROLOGY, 58(2A), 2001, pp. 15-15
Authors:
Fair, WR
Stricker, HJ
Lieberman, R
Bubley, GJ
Trachtenberg, J
Heston, WDW
Citation: Wr. Fair et al., Discussion following Dr. Hans J. Stricker's presentations, UROLOGY, 58(2A), 2001, pp. 27-27
Authors:
Daniell, HW
Chen, S
Fair, WR
Heston, WDW
Pirani, JF
Bubley, GJ
Carroll, PR
Gleave, ME
Citation: Hw. Daniell et al., Discussion following Dr. Sophie Chen's (pages 28-35) and Dr. John F. Pirani's presentations, UROLOGY, 58(2A), 2001, pp. 38-38
Authors:
Fair, WR
Newling, DWW
Carroll, PR
Trachtenberg, J
Daniell, HW
Citation: Wr. Fair et al., Discussion following Dr. Don W. W. Newling's presentation, UROLOGY, 58(2A), 2001, pp. 55-55
Authors:
Trachtenberg, J
Grossfeld, GD
Lubeck, DP
Bubley, GJ
Carroll, PR
Fair, WR
Newling, DWW
Citation: J. Trachtenberg et al., Discussion following Dr. Gary D. Grossfeld's presentation, UROLOGY, 58(2A), 2001, pp. 64-64
Authors:
Lieberman, R
Lubeck, DP
Trachtenberg, J
Stricker, HJ
Newling, DWW
Fair, WR
Carroll, PR
Citation: R. Lieberman et al., The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer - Discussion, UROLOGY, 58(2A), 2001, pp. 99-100
Authors:
Fair, WR
Newling, DWW
Heston, WDW
Trachtenberg, J
Malkowicz, SB
Gleave, ME
Citation: Wr. Fair et al., The role of diethylstilbestrol in the treatment of prostate cancer - Discussion, UROLOGY, 58(2A), 2001, pp. 113-113
Authors:
Brawer, MK
Stamey, TA
Fowler, J
Droller, M
Messing, E
Fair, WR
Citation: Mk. Brawer et al., Perspectives on prostate cancer diagnosis and treatment: A roundtable, UROLOGY, 58(2), 2001, pp. 135-140
Authors:
Ornish, DM
Lee, KL
Fair, WR
Pettengill, EB
Carroll, PR
Citation: Dm. Ornish et al., Dietary trial in prostate cancer: Early experience and implications for clinical trial design, UROLOGY, 57(4A), 2001, pp. 200-201
Authors:
Weinstein, RP
Grob, BM
Pachter, EM
Soloway, S
Fair, WR
Citation: Rp. Weinstein et al., Partial cystectomy during radical surgery for nonurological malignancy, J UROL, 166(1), 2001, pp. 79-81
Authors:
Garnick, MB
Fair, WR
Bostwick, D
Debruyne, F
Fourcroy, J
Grignon, D
Porterfield, H
Sufrin, G
Thrasher, B
Hart, C
Citation: Mb. Garnick et al., Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer - Overview consensus statement, MOL UROL, 4(3), 2000, pp. 89-92
Authors:
Feleppa, EJ
Fair, WR
Liu, T
Kalisz, A
Balaji, KC
Porter, CR
Tsai, H
Reuter, V
Gnadt, W
Miltner, MJ
Citation: Ej. Feleppa et al., Three-dimensional ultrasound analyses of the prostate, MOL UROL, 4(3), 2000, pp. 133-139
Authors:
Fair, WR
Betancourt, JE
Citation: Wr. Fair et Je. Betancourt, Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer, MOL UROL, 4(3), 2000, pp. 241-248
Authors:
Stone, N
Fair, WR
Grignon, D
Bruchovsky, N
Cookson, M
Garnick, M
Sylvester, J
Klotz, L
Zietman, A
Citation: N. Stone et al., Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer - Open discussion following Dr. Fair's presentation, MOL UROL, 4(3), 2000, pp. 249-250
Authors:
Gong, MC
Fair, WR
Citation: Mc. Gong et Wr. Fair, Introduction - Translational research trends: Urologic gene therapy, MOL UROL, 4(2), 2000, pp. 37-38
Authors:
Larchian, WA
Horiguchi, Y
Nair, SK
Fair, WR
Heston, WDW
Gilboa, E
Citation: Wa. Larchian et al., Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: A liposome-mediated gene therapy treatment for bladder cancer, CLIN CANC R, 6(7), 2000, pp. 2913-2920
Authors:
Horiguchi, Y
Larchian, WA
Kaplinsky, R
Fair, WR
Heston, WDW
Citation: Y. Horiguchi et al., Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model, GENE THER, 7(10), 2000, pp. 844-851
Authors:
Garzotto, M
Fair, WR
Citation: M. Garzotto et Wr. Fair, Historical perspective on prostate brachytherapy, J ENDOUROL, 14(4), 2000, pp. 315-318
Authors:
Gschwend, JE
Fair, WR
Vieweg, J
Citation: Je. Gschwend et al., Radical cystectomy for invasive bladder cancer: Contemporary results and remaining controversies, EUR UROL, 38(2), 2000, pp. 121-130
Authors:
Simak, R
Capodieci, P
Cohen, DW
Fair, WR
Scher, H
Melamed, J
Drobnjak, M
Heston, WD
Stix, U
Steiner, G
Cordon-Cardo, C
Citation: R. Simak et al., Expression of c-kit and kit-ligand in benign and malignant prostatic tissues, HIST HISTOP, 15(2), 2000, pp. 365-374
Authors:
Gschwend, JE
Fair, WR
Powell, CT
Citation: Je. Gschwend et al., Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase C alpha, MOLEC PHARM, 57(6), 2000, pp. 1224-1234
Authors:
Garnick, MB
Fair, WR
Goldenberg, SL
Gleave, M
Grignon, D
Fourcroy, J
Sufrin, G
Porterfield, H
Hart, C
Citation: Mb. Garnick et al., Fourth International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer - March 12-13, 1999 - Boston, Massachusetts - Overview consensus statement, MOL UROL, 3(3), 1999, pp. 171-174
Authors:
Fair, WR
Rabbani, F
Bastar, A
Betancourt, J
Citation: Wr. Fair et al., Neoadjuvant hormone therapy before radical prostatectomy: Update on the memorial Sloan-Kettering Cancer Center trials, MOL UROL, 3(3), 1999, pp. 253-260